LYEL Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $9.26

Piyasa Değeri (MRQ) $217M

P/E (TTM) -0.6

Hisse Başına Kâr (TTM) $-16.01

Gelir (TTM) $27.0K

ROE (TTM) -93.3%

52 Haftlık Aralık $9–$40

LYEL Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

Hisse bölünmeleri 1

Ex-tarihi	Bölünme	Tür
02 Haziran 2025	1-for-20	Ters

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Gelir$36.0K

2019-12-31 → 2025-12-31

Hisse Başına Kâr$-16.06

2019-12-31 → 2025-12-31

Serbest Nakit Akışı$-151M

2021-12-31 → 2025-12-31

Net kar marjı-920285.2%

2021-12-31 → 2025-12-31

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	LYEL	5Y ort.	Akran Ortalaması	Sonuç
P/E (TTM)	-0.65Y ort. ≈-36.5	≈-36.5	·	·
F/S (TTM)	8024.35Y ort. ≈31914.9	≈31914.9	14.6	Aşırı değerli
F/D (MRQ)	0.95Y ort. ≈17.7	≈17.7	2.9	Düşük değerli
Fiyat / Serbest Nakit Akışı (TTM)	-1.65Y ort. ≈-74.4	≈-74.4	·	·
Fiyat / Nakit Akışı (TTM)	-1.65Y ort. ≈-97.5	≈-97.5	·	·
Price / Tangible Book (Fiyat / Maddi Defter Değeri)	0.95Y ort. ≈17.7	≈17.7	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	LYEL	5Y ort.	Akran Ortalaması	Sonuç
Faaliyet Kâr Marjı (TTM)	-949981.5%5Y ort. ≈-305742.2%	≈-305742.2%	-752.1%	Zayıf
FAVÖK Marjı (TTM)	-914733.3%5Y ort. ≈-289750.0%	≈-289750.0%	-752.1%	Zayıf
Net Kâr Marjı (TTM)	-920285.2%5Y ort. ≈-301538.5%	≈-301538.5%	-1884.8%	Zayıf
ROA (TTM)	-71.3%5Y ort. ≈-38.3%	≈-38.3%	-27.3%	Zayıf
ROE (TTM)	-93.3%5Y ort. ≈-51.7%	≈-51.7%	-31.2%	Zayıf

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	5 Yıllık trend	LYEL	5Y ort.	Akran Ortalaması	Sonuç
Cari Oran (MRQ)		5.45Y ort. ≈11.9	≈11.9	8.4	Düşük likidite
Quick Ratio (Cari Oran)		5.05Y ort. ≈11.6	≈11.6	5.3	Aynı seviyede

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik	LYEL	5Y ort.	Akran Ortalaması	Sonuç
Revenue YoY (Gelir Yıllık Bazda)	-41.0%5Y ort. ≈107.7%	≈107.7%	·	·
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)	-92.5%5Y ort. ≈-83.0%	≈-83.0%	·	·
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)	-65.8%	·	·	·

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	LYEL	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$-16.065Y ort. ≈$-12.71	≈$-12.71	·	·
Revenue / Share (Hisse Başına Gelir)	$0.005Y ort. ≈$15.74	≈$15.74	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$-8.785Y ort. ≈$-187.92	≈$-187.92	·	·
Cash / Share (Hisse Başına Nakit)	$2.835Y ort. ≈$1.09	≈$1.09	·	·

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik	5 Yıllık trend	LYEL	5Y ort.	Akran Ortalaması	Sonuç
Asset Turnover (Aktif Devir Hızı)		0.05Y ort. ≈0.0	≈0.0	0.3	Zayıf
Revenue / Employee (Çalışan Başına Gelir)		≈$223.60	·	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz -20.5%

Sonraki Rapor Kas 09, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Ağu 10, 2026	$-1.92	$-2.06	6.7%
31 Mart 2026	May 11, 2026	$-1.10	$-2.41	54.4%
31 Aralık 2025		$-7.50	$-2.28	-229.5%
30 Eylül 2025		$-2.13	$-2.70	21.0%
30 Haziran 2025		$-2.89	$-3.65	20.9%
31 Mart 2025		$-3.54	$-3.67	3.6%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 13

Metrik	2025	2024	2023	2022	2021	2020
Revenue	$36.0K	$61.0K	$130.0K	$85M	$11M	$8M
R&D Expense	·	·	$183M	$159M	$139M	$182M
SG&A Expense	$45M	$52M	$67M	$117M	$89M	$47M
Operating Expenses	$269M	$359M	$247M	$272M	$225M	$220M
Operating Income	$-269M	$-359M	$-247M	$-187M	$-215M	$-212M
Other Non-op	$-18M	$5M	$2M	$2M	$-161.0K	$2M
Income Tax	$0	·	·	·	·	·
Net Income	$-274M	$-343M	$-235M	$-183M	$-250M	$-204M
EPS (Basic)	$-16.06	$-26.23	$-18.70	$-0.74	$-1.84	$-15.69
EPS (Diluted)	$-16.06	$-26.23	$-18.70	$-0.74	$-1.84	$-15.69
Shares (Basic)	17,093,000	13,074,000	12,549,000	247,080,000	135,918,000	13,258,000
Shares (Diluted)	17,093,000	13,074,000	12,549,000	247,080,000	135,918,000	13,258,000
EBITDA	$-258M	$-339M	$-227M	$-169M	$-201M	·

Bilanço 21

Metrik	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$60M	$106M	$146M	$124M	$294M	$140M
Short-term Investments	$187M	$265M	$401M	$517M	$321M	$472M
Prepaid Expense	$14M	$9M	$8M	$11M	$11M	$5M
Current Assets	$261M	$380M	$555M	$651M	$626M	$618M
PP&E (Net)	$35M	$48M	$103M	$123M	$120M	$77M
PP&E (Gross)	$109M	$119M	$154M	$155M	$135M	$82M
Accum. Depreciation	$74M	$71M	$52M	$32M	$15M	$5M
Other Non-current Assets	$5M	$5M	$4M	$5M	$3M	$3M
Total Assets	$340M	$491M	$750M	$938M	$1.13B	$908M
Accounts Payable	$3M	$5M	$5M	$4M	$3M	$9M
Current Liabilities	$49M	$54M	$35M	$37M	$47M	$49M
Capital Leases	$42M	$51M	$57M	$63M	$67M	$51M
Other Non-current Liabilities	$517.0K	$3M	$4M	$4M	$5M	$532.0K
Total Liabilities	$92M	$108M	$95M	$104M	$198M	$190M
Common Stock	$2.0K	$1.0K	$25.0K	$25.0K	$24.0K	$2.0K
Paid-in Capital	$1.87B	$1.73B	$1.66B	$1.61B	$1.52B	$41M
Retained Earnings	$-1.62B	$-1.35B	$-1.00B	$-767M	$-584M	$-334M
AOCI	$242.0K	$291.0K	$-94.0K	$-8M	$-2M	$256.0K
Stockholders' Equity	$248M	$383M	$655M	$833M	$930M	$-293M
Liabilities + Equity	$340M	$491M	$750M	$938M	$1.13B	$908M
Shares Outstanding	21,251,000	14,744,000	12,698,000	12,479,000	242,738,000	15,570,000

Nakit Akışı 13

Metrik	2025	2024	2023	2022	2021	2020
D&A	$12M	$20M	$20M	$18M	$14M	$4M
Stock-based Comp	$42M	$33M	$47M	$82M	$62M	$33M
Restructuring	·	·	$6M	·	·	·
Other Non-cash	$71M	$128M	$4M	$-86M	$48M	·
Operating Cash Flow	$-150M	$-162M	$-164M	$-170M	$-126M	$-161M
CapEx	$780.0K	$464.0K	$3M	$24M	$66M	$51M
Investing Cash Flow	$54M	$122M	$184M	$-12M	$-122M	$-274M
Stock Issued	$50M	$0	$0	·	·	·
Stock Repurchased	·	·	·	$0	$0	$12M
Net Stock Activity	$50M	·	·	$0	$0	·
Financing Cash Flow	$50M	$1M	$2M	$11M	$401M	$477M
Net Change in Cash	$-46M	$-39M	$22M	$-170M	$153M	$42M
Free Cash Flow	$-151M	$-163M	$-166M	$-194M	$-192M	·

Kârlılık 5

Metrik	2025	2024	2023	2022	2021	2020
Operating Margin	-748344.4%	-588123.0%	-190006.1%	-220.9%	-2016.7%	·
Net Margin	-762355.6%	-562285.2%	-180486.1%	-216.2%	-2349.5%	·
EBITDA Margin	-716291.7%	-555941.0%	-174429.2%	-199.6%	-1888.8%	·
ROA	-66.1%	-55.3%	-27.8%	-17.7%	-24.6%	·
ROE	-100.3%	-75.1%	-34.7%	-22.1%	-26.1%	·

Likidite ve Solventlik 2

Metrik	Eğilim	2025	2024	2023	2022	2021	2020
Current Ratio		5.3	7.1	16.1	17.6	13.4	·
Quick Ratio		5.0	6.9	15.8	17.3	13.2	·

Verimlilik 1

Metrik	Eğilim	2025	2024	2023	2022	2021	2020
Asset Turnover		0.0	0.0	0.0	0.1	0.0	·

Hisse Başına 5

Metrik	2025	2024	2023	2022	2021	2020
Book Value / Share	$11.68	$1.30	$2.58	$3.34	$3.83	·
Revenue / Share	$0.00	$0.00	$0.00	$0.34	$78.36	·
Cash Flow / Share	$-8.78	$-0.62	$-0.65	$-0.69	$-928.86	·
Cash / Share	$2.83	$0.36	$0.57	$0.50	$1.21	·
EPS (TTM)	$-16.06	$-26.23	$-18.70	$-0.74	$-1.84	·

Büyüme Oranları 3

Metrik	2025	2024	2023	2022	2021	2020
Revenue YoY	-41.0%	-53.1%	-99.9%	695.1%	37.3%	·
Revenue CAGR 3Y	-92.5%	-82.1%	-74.4%	·	·	·
Revenue CAGR 5Y	-65.8%	·	·	·	·	·

Değerleme (TTM) 10

Metrik	2025	2024	2023	2022	2021	2020
Revenue TTM	$36.0K	$61.0K	$130.0K	$85M	$11M	·
Net Income TTM	$-274M	$-343M	$-235M	$-183M	$-250M	·
Market Cap	$654M	$3.77B	$9.85B	$17.32B	$37.58B	·
P/E	-1.9	-0.5	-2.1	-93.8	-84.1	·
P/S	18169.6	61875.6	75796.7	204.5	3528.2	·
P/B	2.6	9.9	15.0	20.8	40.4	·
P / Tangible Book	2.6	9.9	15.0	20.8	40.4	·
P / Cash Flow	-4.4	-23.2	-60.2	-102.1	-297.6	·
P / FCF	-4.3	-23.2	-59.2	-89.4	-196.0	·
Earnings Yield	-52.2%	-204.9%	-48.2%	-1.1%	-1.2%	·

Gelir Tablosu 12

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Revenue	$4.0K	$2.0K	$6.0K	$15.0K	$8.0K	$7.0K	$11.0K	$34.0K	$13.0K	$3.0K	$25.0K	$27.0K	$65.0K	$3.0K	$36M	$553.0K
R&D Expense	$40M	$37M	·	$28M	$35M	$43M	·	$40M	$40M	$43M	$44M	$47M	$45M	$42M	$44M	$36M
SG&A Expense	$10M	$10M	$11M	$11M	$10M	$14M	$15M	$12M	$12M	$13M	$16M	$19M	$19M	$26M	$30M	$34M
Operating Expenses	$47M	$44M	$128M	$37M	$47M	$57M	$201M	$51M	$52M	$56M	$59M	$66M	$63M	$66M	$73M	$69M
Operating Income	$-47M	$-44M	$-128M	$-37M	$-47M	$-57M	$-201M	$-51M	$-52M	$-56M	$-59M	$-66M	$-63M	$-66M	$-37M	$-69M
Other Non-op	$398.0K	$18M	$-16M	$-5M	$1M	$1M	$4M	$-43.0K	$-645.0K	$1M	$2M	$-326.0K	$1M	$-1M	$-14.0K	$35.0K
Net Income	$-45M	$-24M	$-141M	$-39M	$-43M	$-52M	$-192M	$-45M	$-46M	$-61M	$-51M	$-64M	$-67M	$-70M	$-36M	$-68M
EPS (Basic)	$-1.92	$-1.10	$-10.86	$-2.13	$-2.89	$-3.54	$-18.92	$-3.48	$-3.59	$-0.24	$-0.20	$-0.26	$-0.27	$-0.28	$-0.15	$-0.28
EPS (Diluted)	$-1.92	$-1.10	$-10.86	$-2.13	$-2.89	$-3.54	$-18.92	$-3.48	$-3.59	$-0.24	$-0.20	$-0.26	$-0.27	$-0.28	$-0.15	$-0.28
Shares (Basic)	23,364,000	21,876,000	·	18,268,000	14,793,000	14,755,000	·	12,815,000	12,770,000	254,252,000	251,318,000	250,204,000	249,591,000	248,320,000	246,312,000	244,178,000
Shares (Diluted)	23,364,000	21,876,000	·	18,268,000	14,793,000	14,755,000	·	12,815,000	12,770,000	254,252,000	251,318,000	250,204,000	249,591,000	248,320,000	246,312,000	244,178,000
EBITDA	$-47M	$-42M	·	$-37M	$-47M	$-54M	·	$-51M	·	$-51M	$-59M	$-66M	$-58M	$-66M	$-37M	$-64M

Bilanço 21

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Cash & Equivalents	$73M	$91M	$60M	$124M	$99M	$120M	$106M	$100M	$133M	$126M	$286M	$224M	$109M	$116M	$206M	$223M
Short-term Investments	$131M	$163M	$187M	$196M	$178M	$181M	$265M	$340M	$358M	$401M	$289M	$371M	$503M	$532M	$450M	$391M
Prepaid Expense	$9M	$13M	$14M	$9M	$5M	$8M	$9M	$9M	$9M	$8M	$11M	$11M	$12M	$12M	$11M	$12M
Current Assets	$214M	$267M	$261M	$328M	$282M	$309M	$380M	$450M	$500M	$534M	$587M	$606M	$624M	$660M	$667M	$626M
PP&E (Net)	$31M	$33M	$35M	$37M	$39M	$44M	$48M	$88M	$93M	$98M	$108M	$114M	$119M	$126M	$128M	$126M
PP&E (Gross)	·	·	$109M	·	·	·	$119M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$74M	·	·	·	$71M	·	·	·	·	·	·	·	·	·
Other Non-current Assets	$6M	$5M	$5M	$3M	$3M	$3M	$5M	$5M	$4M	$4M	$4M	$5M	$5M	$3M	$4M	$4M
Total Assets	$311M	$351M	$340M	$408M	$385M	$430M	$491M	$619M	$654M	$694M	$795M	$835M	$880M	$977M	$1.02B	$1.07B
Accounts Payable	$4M	$5M	$3M	$3M	$3M	$4M	$5M	$4M	$4M	$5M	$4M	$6M	$6M	$5M	$4M	$7M
Current Liabilities	$40M	$37M	$49M	$32M	$37M	$41M	$54M	$34M	$31M	$32M	$35M	$34M	$31M	$51M	$50M	$41M
Capital Leases	$37M	$39M	$42M	$44M	$47M	$49M	$51M	$51M	$53M	$55M	$59M	$60M	$62M	$65M	$66M	$67M
Other Non-current Liabilities	$537.0K	$527.0K	$517.0K	$3M	$3M	$3M	$3M	$4M	$3M	$4M	$4M	$4M	$4M	$4M	$4M	$4M
Total Liabilities	$77M	$77M	$92M	$79M	$87M	$93M	$108M	$89M	$88M	$91M	$97M	$98M	$97M	$157M	$154M	$191M
Common Stock	$2.0K	$2.0K	$2.0K	$2.0K	$1.0K	$30.0K	$1.0K	$26.0K	$26.0K	$25.0K	$25.0K	$25.0K	$25.0K	$25.0K	$25.0K	$25.0K
Paid-in Capital	$1.92B	$1.92B	$1.87B	$1.81B	$1.74B	$1.73B	$1.73B	$1.68B	$1.68B	$1.67B	$1.65B	$1.64B	$1.62B	$1.59B	$1.57B	$1.54B
Retained Earnings	$-1.69B	$-1.64B	$-1.62B	$-1.48B	$-1.44B	$-1.40B	$-1.35B	$-1.15B	$-1.11B	$-1.06B	$-949M	$-898M	$-834M	$-759M	$-689M	$-653M
AOCI	$-158.0K	$-9.0K	$242.0K	$201.0K	$57.0K	$158.0K	$291.0K	$760.0K	$-397.0K	$-404.0K	$-1M	$-2M	$-4M	$-10M	$-8M	$-7M
Stockholders' Equity	$234M	$274M	$248M	$329M	$299M	$337M	$383M	$531M	$567M	$603M	$698M	$737M	$784M	$820M	$868M	$881M
Liabilities + Equity	$311M	$351M	$340M	$408M	$385M	$430M	$491M	$619M	$654M	$694M	$795M	$835M	$880M	$977M	$1.02B	$1.07B
Shares Outstanding	23,397,000	23,328,000	21,251,000	19,294,000	14,831,000	295,284,000	14,744,000	256,564,000	255,948,000	254,927,000	251,869,000	251,027,000	249,609,000	249,240,000	247,110,000	245,423,000

Nakit Akışı 10

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
D&A	$2M	$2M	$2M	$3M	$3M	$3M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$4M	$4M
Stock-based Comp	$5M	$4M	$26M	$5M	$5M	$6M	$8M	$8M	$8M	$9M	$11M	$14M	$14M	$19M	$22M	$22M
Other Non-cash	·	$-21M	·	·	·	$-12M	·	·	·	$4M	·	·	$2M	·	·	$-6M
Operating Cash Flow	$-34M	$-39M	$-32M	$-29M	$-34M	$-55M	$-47M	$-35M	$-38M	$-42M	$-38M	$-39M	$-46M	$-37M	$-44M	$-48M
CapEx	$256.0K	$89.0K	$304.0K	$62.0K	$168.0K	$246.0K	$44.0K	$59.0K	$331.0K	$30.0K	$195.0K	$933.0K	$2M	$3M	$7M	$10M
Investing Cash Flow	$16M	$17M	$-31M	$3M	$13M	$69M	$54M	$2M	$45M	$22M	$100M	$153M	$32M	$-57M	$25M	$-26M
Stock Issued	·	·	$0	·	·	·	$0	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$522.0K	$52M	$222.0K	$50M	$183.0K	$1.0K	$437.0K	$0	$862.0K	$27.0K	$-143.0K	$1M	$-69.0K	$5M	$2M	$3M
Net Change in Cash	$-18M	$31M	$-63M	$25M	$-22M	$15M	$7M	$-33M	$8M	$-20M	$62M	$115M	$-14M	$-89M	$-17M	$-71M
Free Cash Flow	·	$-39M	·	·	·	$-55M	·	·	·	$-42M	·	·	$-48M	·	·	$-58M

Kârlılık 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Operating Margin	-1183425.0%	-2213050.0%	·	-248353.3%	-589250.0%	-819528.6%	·	-148544.1%	·	-1852500.0%	-236156.0%	-244092.6%	-96240.0%	-2214566.7%	-104.2%	-12400.7%
Net Margin	-1118875.0%	-1207650.0%	·	-258973.3%	-533550.0%	-745642.9%	·	-131126.5%	·	-2022233.3%	-203412.0%	-236629.6%	-103013.9%	-2341800.0%	-101.6%	-12322.6%
EBITDA Margin	-1183425.0%	-2096450.0%	·	-248353.3%	-589250.0%	-770371.4%	·	-148544.1%	·	-1685033.3%	-236156.0%	-244092.6%	-88506.2%	-2214566.7%	-104.2%	-11643.6%
ROA	-12.8%	-6.2%	·	-7.6%	-8.2%	-9.3%	·	-6.3%	·	-7.7%	-5.7%	-6.9%	-6.9%	-6.5%	-3.2%	-12.7%
ROE	-16.8%	-7.9%	·	-9.0%	-9.9%	-11.1%	·	-7.3%	·	-8.8%	-6.7%	-8.0%	-8.0%	-7.8%	-3.8%	-15.5%

Likidite ve Solventlik 2

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Current Ratio		5.4	7.2	·	10.3	7.6	7.5	·	13.4	·	16.5	16.7	17.6	20.3	12.9	13.3	15.2
Quick Ratio		5.1	6.9	·	10.0	7.5	7.3	·	13.1	·	16.3	16.4	17.3	19.9	12.7	13.0	15.0

Verimlilik 1

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	0.0	·	0.0	0.0	0.0	0.0	0.0	0.0	0.0

Hisse Başına 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Book Value / Share	$9.99	$11.73	·	$17.06	$20.16	$1.14	·	$2.07	·	$2.37	$2.77	$2.94	$3.14	$3.29	$3.51	$3.59
Revenue / Share	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	·	$0.00	$0.00	$0.00	$0.00	$0.00	$0.15	$0.00
Cash Flow / Share	·	$-1.76	·	·	·	$-0.19	·	·	·	$-0.17	·	·	$-0.19	·	·	$-0.20
Cash / Share	$3.12	$3.89	·	$6.40	$6.66	$0.41	·	$0.39	·	$0.49	$1.14	$0.89	$0.44	$0.47	$0.83	$0.91
EPS (TTM)	$-16.01	$-16.98	·	$-27.48	$-28.83	$-29.53	·	$-25.28	$-22.00	$-18.67	$-0.76	$-0.84	$-0.73	$2.31	$2.39	$1.07

Değerleme (TTM) 9

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Revenue TTM	$27.0K	$31.0K	·	$41.0K	$60.0K	$65.0K	·	$63.0K	$54.0K	$68.0K	$49M	$48M	$84M	$39M	$42M	$9M
Net Income TTM	$-248M	$-246M	·	$-326M	$-331M	$-335M	·	$-204M	$-210M	$-228M	$-190M	$-210M	$-182M	$-258M	$-237M	$-263M
Market Cap	$329M	$468M	·	$313M	$131M	$3.18B	·	$7.08B	·	$11.37B	$7.40B	$15.97B	$11.78B	$36.54B	$32.22B	$24.79B
P/E	-0.9	-1.2	·	-0.6	-0.3	-0.4	·	-1.1	-1.3	-2.4	-38.7	-75.7	-64.7	63.5	54.6	94.4
P/S	12175.1	15095.5	·	7642.3	2185.1	48880.9	·	112399.5	·	167202.1	152.7	329.3	139.9	934.0	769.6	2830.3
P/B	1.4	1.7	·	1.0	0.4	9.4	·	13.3	·	18.9	10.6	21.7	15.0	44.6	37.1	28.1
P / Tangible Book	1.4	1.7	·	1.0	0.4	9.4	·	13.3	13.1	18.9	10.6	21.7	15.0	44.6	37.1	28.1
P / Cash Flow	·	-12.2	·	·	·	-58.0	·	·	·	-270.6	·	·	-254.9	·	·	-518.0
Earnings Yield	-113.9%	-84.7%	·	-169.2%	-326.1%	-274.4%	·	-91.6%	-75.9%	-41.9%	-2.6%	-1.3%	-1.6%	1.6%	1.8%	1.1%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$36.0K	$61.0K	$130.0K	$85M	$11M
Faaliyet Kâr Marjı %	-748344.4%	-588123.0%	-190006.1%	-220.9%	-2016.7%
Net Gelir	$-274M	$-343M	$-235M	$-183M	$-250M
Seyreltilmiş Hisse Başı Kâr	$-16.06	$-26.23	$-18.70	$-0.74	$-1.84

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Cari Oran	5.3	7.1	16.1	17.6	13.4
Cari Oran	5.0	6.9	15.8	17.3	13.2

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$-151M	$-163M	$-166M	$-194M	$-192M

Kurumsal Sahipler (13F) 95 dosya · $240.0M toplam · Tarih itibarıyla 30 Haziran 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 95

Tutulan Değer $240.0M

Yeni pozisyonlar 26

Çıkan pozisyonlar 9

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
26 (+6 önceki Ç'ye göre)	9 (+3 önceki Ç'ye göre)	29 (+4 önceki Ç'ye göre)	19 (+11 önceki Ç'ye göre)	+67K

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
ARCH Venture Management, LLC	$45.525.211	3.247.162	18,97%	Hisse senetleri
MWG Caph Ltd	$31.029.810	1.008.116	12,93%	Hisse senetleri
VANGUARD GROUP INC	$25.437.516	826.430	10,60%	Hisse senetleri
GSK plc	$21.252.859	1.512.659	8,86%	Hisse senetleri
MWG Management Ltd.	$16.371.804	1.008.116	6,82%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$11.054.175	786.774	4,61%	Hisse senetleri
Orland Properties Ltd	$10.603.507	754.698	4,42%	Hisse senetleri
BlackRock, Inc.	$10.177.005	724.342	4,24%	Hisse senetleri
Almitas Capital LLC	$8.168.768	581.407	3,40%	Hisse senetleri
Foresite Capital Management V, LLC	$6.693.223	476.386	2,79%	Hisse senetleri
MILLENNIUM MANAGEMENT LLC	$5.162.996	367.473	2,15%	Hisse senetleri
Opaleye Management Inc.	$4.833.551	344.025	2,01%	Hisse senetleri
venBio Partners LLC	$4.744.643	337.697	1,98%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$4.365.887	310.636	1,82%	Hisse senetleri
Alphabet Inc.	$4.120.247	293.256	1,72%	Hisse senetleri
STATE STREET CORP	$2.603.774	185.322	1,08%	Hisse senetleri
HSG Holding Ltd	$2.139.801	152.299	0,89%	Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC	$1.829.169	130.190	0,76%	Hisse senetleri
NORTHERN TRUST CORP	$1.664.925	118.500	0,69%	Hisse senetleri
Qube Research & Technologies Ltd	$1.552.961	110.531	0,65%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1.511.359	107.570	0,63%	Hisse senetleri
MARSHALL WACE, LLP	$1.493.516	106.300	0,62%	Hisse senetleri
Velan Capital Investment Management LP	$1.475.250	105.000	0,61%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$1.307.985	93.095	0,54%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$1.291.069	91.891	0,54%	Hisse senetleri
MIC Capital Management UK LLP	$1.222.743	87.028	0,51%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$1.219.245	86.779	0,51%	Hisse senetleri
DIMENSIONAL FUND ADVISORS LP	$957.066	68.315	0,40%	Hisse senetleri
TWO SIGMA INVESTMENTS, LP	$743.624	52.927	0,31%	Hisse senetleri
JANE STREET GROUP, LLC	$646.455	46.011	0,27%	Hisse senetleri
Squarepoint Ops LLC	$594.624	42.322	0,25%	Hisse senetleri
Ikarian Capital, LLC	$577.188	41.081	0,24%	Hisse senetleri
MORGAN STANLEY	$520.553	37.050	0,22%	Hisse senetleri
CANADA PENSION PLAN INVESTMENT BOARD	$413.225	29.411	0,17%	Hisse senetleri
Point72 Asset Management, L.P.	$366.424	26.080	0,15%	Hisse senetleri
UBS Group AG	$365.048	25.982	0,15%	Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$363.895	25.900	0,15%	Alım opsiyonu
Bank of New York Mellon Corp	$346.656	24.673	0,14%	Hisse senetleri
AMERICAN CENTURY COMPANIES INC	$344.787	24.540	0,14%	Hisse senetleri
Jump Financial, LLC	$308.482	21.956	0,13%	Hisse senetleri
Clearstead Advisors, LLC	$280.410	19.958	0,12%	Hisse senetleri
EntryPoint Capital, LLC	$272.710	19.410	0,11%	Hisse senetleri
CITADEL ADVISORS LLC	$262.665	18.695	0,11%	Hisse senetleri
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$252.900	18.000	0,11%	Hisse senetleri
CITADEL ADVISORS LLC	$251.495	17.900	0,10%	Satım opsiyonu
Susquehanna Portfolio Strategies, LLC	$251.144	17.875	0,10%	Hisse senetleri
CITADEL ADVISORS LLC	$238.850	17.000	0,10%	Alım opsiyonu
Allspring Global Investments Holdings, LLC	$226.837	16.145	0,09%	Hisse senetleri
RHUMBLINE ADVISERS	$217.234	15.462	0,09%	Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$199.510	14.200	0,08%	Satım opsiyonu

Tüm 95 kurumsal sahibi göster →

Şirket yöneticileri 25 içeriden öğrenenler · 14 yöneticiler · 11 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Satışlar 12ay	Net 12ay
Lynn Seely	President and CEO	21 Ağustos 2026 S	63.899	6	$-353.079
Elizabeth Homans	Chief Executive Officer	16 Mart 2022 A	·	0	$0
Charles W. Newton	Chief Financial Officer	21 Ağustos 2025 S	15.306	0	$0
Stephen J. Hill	Chief Operating Officer	21 Ağustos 2026 S	16.816	6	$-51.290
Jarrad Mattieu Aguirre	Chief Medical Officer	10 Eylül 2026 A	·	0	$0
David Shook	Chief Medical Officer	10 Eylül 2026 S	20.423	2	$-31.339
Gary K. Lee	Chief Scientific Officer	21 Ağustos 2026 S	16.220	6	$-71.695
Veronica Sanchez Bulis	VP, Corporate Controller	10 Ağustos 2026 S	14.799	6	$-96.909
Smital Shah	Chief Fin. and Bus. Officer	09 Mart 2026 A	·	0	$0
Mark A Meltz	General Counsel	10 Şubat 2026 A	·	0	$0
Matthew Lang	Chief Business Officer	10 Şubat 2025 A	162.500	0	$0
Tina M. Albertson	Chief Medical Officer	24 Şubat 2023 A	·	0	$0
Rahsaan Thompson	Chief Legal Officer	24 Şubat 2023 A	·	0	$0
Heather D Turner	Chief General Counsel	16 Mart 2022 A	·	0	$0
Mark Bachleda	Yönetim kurulu üyesi	10 Haziran 2026 A	·	0	$0
Elizabeth G Nabel	Yönetim kurulu üyesi	10 Haziran 2026 A	·	0	$0
Richard Klausner	Yönetim kurulu üyesi	10 Haziran 2026 A	843.365	0	$0
Sumant Ramachandra	Yönetim kurulu üyesi	10 Haziran 2026 A	200.000	0	$0
Cathy Friedman	Yönetim kurulu üyesi	10 Haziran 2026 A	236.370	0	$0
Otis W Brawley	Yönetim kurulu üyesi	10 Haziran 2026 A	35.640	0	$0
William Jl Rieflin	Yönetim kurulu üyesi	10 Haziran 2026 A	·	0	$0
Hans Edgar Bishop	Yönetim kurulu üyesi	14 Haziran 2024 A	4.685.614	0	$0
Robert Nelsen	Yönetim kurulu üyesi	14 Haziran 2024 A	18.206.358	0	$0
Innovative Cellular Therapeutics Holdings Ltd	10% sahip	27 Temmuz 2026 J	2.818.980	2	$-274
GSK plc	·	21 Haziran 2021 C	30.253.189	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 16 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
IWC · iShares Trust	0,03%	32.319 SH	11 Eylül 2026	Günlük
IBBQ · Invesco Exchange-Traded Fund Trust …	0,01%	1.674 SH	02 Ekim 2026	Günlük
VTWV · VANGUARD SCOTTSDALE FUNDS	0,01%	8.183 SH	19 Ağustos 2026	Günlük
IBB · iShares Trust	0,01%	57.662 SH	11 Eylül 2026	Günlük
RSSL · Global X Funds	0,00%	4.474 NS	31 Temmuz 2026	N-PORT
IWM · iShares Trust	0,00%	222.823 SH	11 Eylül 2026	Günlük
PRFZ · Invesco Exchange-Traded Fund Trust	0,00%	8.835 SH	02 Ekim 2026	Günlük
DCOR · Dimensional ETF Trust	0,00%	1.961 NS	31 Temmuz 2026	N-PORT
DFAS · Dimensional ETF Trust	0,00%	1.736 NS	31 Temmuz 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	163.755 SH	19 Ağustos 2026	Günlük
VTI · VANGUARD INDEX FUNDS	0,00%	604.461 SH	19 Ağustos 2026	Günlük
VTWO · VANGUARD SCOTTSDALE FUNDS	0,00%	54.398 SH	19 Ağustos 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	1.151 SH	19 Ağustos 2026	Günlük
DFAC · Dimensional ETF Trust	0,00%	409 NS	31 Temmuz 2026	N-PORT
VHT · VANGUARD WORLD FUND	0,00%	28.159 SH	19 Ağustos 2026	Günlük
IWN · iShares Trust	·	89.130 SH	11 Eylül 2026	Günlük

LYEL Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 14 analist AL

Medyan hedef $41.50 +348,2%

4 28,6% Güçlü Al

8 57,1% Al

1 7,1% Tut

1 7,1% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

8 analist · 2026-10-02

Ortalama hedef $37.88 +309,0%

← Tüm hedeflerin altında Mevcut fiyat $9.26

Düşük$12.00 Ortalama$37.88 Yüksek$49.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
LYEL	$654M	-1.9	-41.0%	-762355.6%	-100.3%	·
CAMP	$318M	-2.3	436.5%	-2298.5%	-183.4%	·
EVMN	$540M	-1.5	85.7%	-529.8%	-401.2%	·
AKBA	$427M	-80.5	47.5%	-2.3%	-17.3%	·
IVVD	$697M	-8.2	110.5%	-98.2%	-36.9%	·
MGNX	$102M	-1.4	-0.31%	-49.9%	-87.0%	·
KROS	$398M	8.9	·	35.7%	17.2%	·
RNAC	$188M	-1.4	-92.8%	-4658.6%	202.4%	·
SION	$1.84B	-21.9	·	·	-23.4%	·

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

LYEL Lyell Immunopharma, Inc. - Common Stock